Developments of subunit and VLP vaccines against influenza a virus-Reference-Cited by-同舟云学术

Developments of subunit and VLP vaccines against influenza a virus

Published:2012-06 Issue:3 Volume:27 Page:145-153
ISSN:1674-0769
Container-title:Virologica Sinica
language:en
Short-container-title:Virol. Sin.

Author:

Deng Ma-ping,Hu Zhi-hong,Wang Hua-lin,Deng Fei

Publisher

Elsevier BV

Subject

Virology,Molecular Medicine,Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12250-012-3241-1.pdf

Reference54 articles.

1. Altstein A D, Gitelman A K, Smirnov Y A, et al. 2006. Immunization with influenza a np-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol, 151(5): 921–931.

2. Barefoot B E, Sample C J, Ramsburg E A. 2009. Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces cd8 t-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus. Clin Vaccine Immunol, 16(4): 488–498.

3. Biesova Z, Miller M A, Schneerson R, et al. 2009. Preparation, characterization, and immunogenicity in mice of a recombinant influenza h5 hemagglutinin vaccine against the avian h5n1 a/vietnam/1203/2004 influenza virus. Vaccine, 27(44): 6234–6238.

4. Brands R, Visser J, Medema J, et al. 1999. Influvac: A safe madin darby canine kidney (mdck) cell culture-based influenza vaccine. Dev Biol Stand, 98: 93–100; discussion 111.

5. Brett I C, Johansson B E. 2005. Immunization against influenza a virus: Comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology, 339(2): 273–280.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outlining recent updates on influenza therapeutics and vaccines: A comprehensive review;Vaccine: X;2024-03

2. Lentinan-functionalized PBAE-G-nanodiamonds as an adjuvant to induce cGAS-STING pathway-mediated macrophage activation and immune enhancement;Journal of Pharmaceutical Analysis;2023-12

3. A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice;2023-05-08

4. A subunit vaccine candidate based on the Spike protein of SARS-CoV-2 prevents infectious virus shedding in cats;Research in Veterinary Science;2022-11

5. Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies;Applied Microbiology and Biotechnology;2021-10-07